Nalaganje...
P01.03 mTORC1 activation sensitizes human malignant glioma cells to hypoxia-induced cell death by increasing O2-consumption
Glioblastoma (GB) is an incurable brain cancer with median survival of less than one year in unselected cohorts. Current treatment of recurrent tumors frequently involves the VEGF-A-targeting antibody bevacizumab that causes local therapeutic hypoxia. After initial chemotherapy activating mutations...
Shranjeno v:
| izdano v: | Neuro Oncol |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Oxford University Press
2016
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5782559/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/now188.060 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|